Other SMARCA4-deficient malignant tumors, such as malignant rhabdoid tumor (MRT) and SCCOHT, differ from SMARCA4-UT in tumor extension and patient age, occurring mostly in young children. Here, SMARCA4 is linked to neoplasm.